DEPARTMENT OF LABOR
Employment and Training Administration

TA-W-94,371

SUN PHARMACEUTICAL INDUSTRIES, INC.
A SUBSIDIARY OF SUN PHARMACEUTICAL HOLDING, USA
CRANBURY DIVISION
CRANBURY, NEW JERSEY

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended ("Act"), 19 U.S.C. § 2273, the Department of Labor
herein presents the results of an investigation regarding
certification of eligibility to apply for worker adjustment
assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the
workers in such workers' firm have become totally or
partially separated, or are threatened to become
totally or partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of
articles or supply of services like or directly
competitive with those produced/supplied by the
workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have contributed
importantly to the workers' separation or
threat of separation.

The investigation was initiated in response to a
petition filed on November 30, 2018 by a company official on
behalf of the workers of Sun Pharmaceutical Industries, Inc., a
subsidiary of Sun Pharmaceutical Holding, USA, Cranbury Division,
Cranbury, New Jersey are the subject of this investigation. The
workers' firm is engaged in activities related to the production
of prescription drugs.
The worker group is also comprised of remote workers
reporting from New York and Pennsylvania.
During the course of the investigation, information was
collected from the petitioner and the workers' firm.
Section 222(a)(1) has been met because a significant
number or proportion of the workers at Sun Pharmaceutical have
become totally or partially separated, or are threatened to
become totally or partially separated.
Section 222(a)(2)(B) has been met because the workers'
firm has shifted to a foreign country the production of articles
like or directly competitive with the articles produced by the
workers which contributed importantly to worker group
separations at Sun Pharmaceutical.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Sun Pharmaceutical
Industries, Inc., a subsidiary of Sun Pharmaceutical Holding,
USA, Cranbury Division, Cranbury, New Jersey, who are engaged in
activities related to the production of prescription drugs meet
the worker group certification criteria under Section 222(a) of
the Act, 19 U.S.C. § 2272(a). In accordance with Section 223 of
the Act, 19 U.S.C. § 2273, I make the following certification:
"All workers of Sun Pharmaceutical Industries, Inc., a
subsidiary of Sun Pharmaceutical Holding, USA, Cranbury
Division, Cranbury, New Jersey who became totally or
partially separated from employment on or after November
29, 2017 through two years from the date of certification,
and all workers in the group threatened with total or
partial separation from employment on the date of
certification through two years from the date of
certification, are eligible to apply for adjustment
assistance under Chapter 2 of Title II of the Trade Act of
1974, as amended."
Signed in Washington, D.C. this 28th day of December 2018.

/s/Jacquelyn R. Mendelsohn
______________________________
JACQUELYN R. MENDELSOHN
Certifying Officer, Office of
Trade Adjustment Assistance